D. E. Shaw Co., a fund founded by billionaire quant David Shaw, has disclosed its position in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) in a recent filing with the Securities and Exchange Commission. According to the 13G filing, D. E. Shaw owns 1.73 million shares of AMAG, which represent 5.0% of the company’s outstanding stock. The position is passive by nature.
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
D. E. Shaw Co., L.P. 13-3695715 | 1,729,526 | 1,735,509 | 1,735,509 | 5.0% | ||
David E. Shaw | 1,729,526 | 1,735,509 | 1,735,509 | 5.0% |
Page 1 of 6 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
AMAG Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.01
(Title of Class of Securities)
00163U106
(CUSIP Number)
January 4, 2016
(Date of Event Which Requires Filing of this
Statement)
Check the following box to designate the rule pursuant to which
the Schedule is filed:
¨ | Rule 13d-1(b) |
x | Rule 13d-1(c) |
¨ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 2 of 6 SEC Filing
CUSIP No. 00163U106 | |||||
1. | Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) D. E. Shaw & Co., L.P. 13-3695715 | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | ¨ | ||||
(b) | ¨ | ||||
3. | SEC Use Only | ||||
4. | Citizenship or Place of Organization Delaware | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power -0- | |||
6. | Shared Voting Power 1,729,526 | ||||
7. | Sole Dispositive Power -0- | ||||
8. | Shared Dispositive Power 1,735,509 | ||||
9. | Aggregate Amount Beneficially Owned by Each Reporting Person 1,735,509 | ||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares | ||||
11. | Percent of Class Represented by Amount in Row (9) 5.0% | ||||
12. | Type of Reporting Person (See Instructions) IA, PN | ||||
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 3 of 6 SEC Filing
CUSIP No. 00163U106 | |||||
1. | Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) David E. Shaw | ||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) | ||||
(a) | ¨ | ||||
(b) | ¨ | ||||
3. | SEC Use Only | ||||
4. | Citizenship or Place of Organization United States | ||||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power -0- | |||
6. | Shared Voting Power 1,729,526 | ||||
7. | Sole Dispositive Power -0- | ||||
8. | Shared Dispositive Power 1,735,509 | ||||
9. | Aggregate Amount Beneficially Owned by Each Reporting Person 1,735,509 | ||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares | ||||
11. | Percent of Class Represented by Amount in Row (9) 5.0% | ||||
12. | Type of Reporting Person (See Instructions) IN | ||||
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 4 of 6 SEC Filing
Item 1. | ||
(a) | Name of Issuer | |
AMAG Pharmaceuticals, Inc. | ||
(b) | Address of Issuer’s Principal Executive Offices | |
1100 Winter Street | ||
Waltham, Massachusetts 02451 | ||
Item 2. | ||
(a) | Name of Person Filing | |
D. E. Shaw & Co., L.P. | ||
David E. Shaw | ||
(b) | Address of Principal Business Office or, if none, Residence | |
The business address for each reporting person is: | ||
1166 Avenue of the Americas, 9th Floor | ||
New York, NY 10036 | ||
(c) | Citizenship | |
D. E. Shaw & Co., L.P. is a limited partnership organized under the laws of the state of Delaware. | ||
David E. Shaw is a citizen of the United States of America. | ||
(d) | Title of Class of Securities | |
Common Stock, par value $0.01 | ||
(e) | CUSIP Number | |
00163U106 |
Item 3. | If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: |
Not Applicable | |
Item 4. | Ownership |
As of January 4, 2016:
(a) | Amount beneficially owned: |
D. E. Shaw & Co., L.P.: | 1,735,509 shares This is composed of (i) 1,051,098 shares in the name of D. E. Shaw |
David E. Shaw: | 1,735,509 shares This is composed of (i) 1,051,098 shares in the name of D. E. Shaw |
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 5 of 6 SEC Filing
(b) | Percent of class: |
D. E. Shaw & Co., L.P.: | 5.0% |
David E. Shaw: | 5.0% |
(c) | Number of shares to which the person has: |
(i) | Sole power to vote or to direct the vote: |
D. E. Shaw & Co., L.P.: | -0- shares |
David E. Shaw: | -0- shares |
(ii) | Shared power to vote or to direct the vote: |
D. E. Shaw & Co., L.P.: | 1,729,526 shares |
David E. Shaw: | 1,729,526 shares |
(iii) | Sole power to dispose or to direct the disposition of: |
D. E. Shaw & Co., L.P.: | -0- shares |
David E. Shaw: | -0- shares |
(iv) | Shared power to dispose or to direct the disposition of: |
D. E. Shaw & Co., L.P.: | 1,735,509 shares |
David E. Shaw: | 1,735,509 shares |
David E. Shaw does not own any shares directly. By virtue of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co., Inc., which is the general partner of D. E. Shaw & Co., L.P., which in turn is the manager and investment adviser of D. E. Shaw Valence Portfolios, L.L.C., the investment
adviser of D. E. Shaw Oculus Portfolios, L.L.C., and the managing member of (i) D. E. Shaw Investment Management, L.L.C., and (ii)
D. E. Shaw Heliant Adviser, L.L.C., which in turn is the investment adviser of D. E. Shaw Heliant Capital, L.L.C., and by virtue
of David E. Shaw’s position as President and sole shareholder of D. E. Shaw & Co. II, Inc., which is the managing member
of D. E. Shaw & Co., L.L.C., which in turn is the manager of D. E. Shaw Oculus Portfolios, L.L.C. and the managing
member of (i) D. E. Shaw Heliant Manager, L.L.C., which in turn is the manager of D. E. Shaw Heliant Capital, L.L.C., David E. Shaw may be deemed to have the shared power to vote or direct the vote of 1,729,526 shares, and the shared power to dispose or
direct the disposition of 1,735,509 shares, the 1,735,509 shares as described above constituting 5.0% of the outstanding shares
and, therefore, David E. Shaw may be deemed to be the beneficial owner of such shares. David E. Shaw disclaims beneficial
ownership of such 1,735,509 shares.
Item 5. | Ownership of Five Percent or Less of a Class |
Not Applicable | |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable | |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person. |
Not Applicable | |
Item 8. | Identification and Classification of Members of the Group |
Not Applicable | |
Item 9. | Notice of Dissolution of Group |
Not Applicable | |
Item 10. | Certification |
By signing below, each of D. E. Shaw & Co., L.P.
and David E. Shaw certify that, to the best of such reporting person’s knowledge and belief, the securities referred to
above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such
purposes or effect.
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 6 of 6 SEC Filing
SIGNATURE
After reasonable inquiry and to the best of their knowledge and
belief, the undersigned certify that the information set forth in this statement is true, complete and correct. A Power of Attorney,
dated December 16, 2014, granted by David E. Shaw in favor of Nathan Thomas, is attached hereto.
Dated: January 14, 2016
D. E. Shaw & Co., L.P. | ||
By: | /s/ Nathan Thomas | |
Nathan Thomas | ||
Chief Compliance Officer | ||
David E. Shaw | ||
By: | /s/ Nathan Thomas | |
Nathan Thomas | ||
Attorney-in-Fact for David E. Shaw |